Runx2 regulates FGF2‐induced Bmp2 expression during cranial bone development

Calvarial bone is formed by the intramembranous bone‐forming process, which involves many signaling molecules. The constitutive activation of the fibroblast growth factor (FGF) signaling pathway accelerates osteoblast differentiation and results in premature cranial suture closure. Bone morphogenetic protein (BMP) signaling pathways, which involve the downstream transcription factors Dlx5 and Msx2, are also involved in the bone‐forming processes. However, the relationships between these two main signaling cascades are still unclear. We found that FGF2 treatment of developing bone fronts stimulated Bmp2 gene expression but that BMP2 treatment could not induce Fgf2 expression. Moreover, the disruption of the Runx2 gene completely eliminated the expression of Bmp2 and its downstream genes Dlx5 and Msx2 in the developing primordium of bone, while the expression of Fgf2 was maintained. In addition, cultured Runx2−/− cells expressed very low baseline levels of Bmp2 that were up‐regulated by transfection with a Runx2‐expressing plasmid. These levels in turn were markedly elevated by FGF2 treatment. FGF2 treatment also strongly enhanced the Bmp2 expression in MC3T3‐E1 cells, whose endogenous Runx2 gene is intact and which express Bmp2 at low baseline levels as well. These results indicate that Runx2 is an important mediator of the expression of Bmp2 in response to FGF stimulation in cranial bone development. Developmental Dynamics 233:115–121, 2005. © 2005 Wiley‐Liss, Inc.

[1]  H. Ryoo,et al.  The Protein Kinase C Pathway Plays a Central Role in the Fibroblast Growth Factor-stimulated Expression and Transactivation Activity of Runx2* , 2003, The Journal of Biological Chemistry.

[2]  S. Mundlos,et al.  Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development , 1997, Cell.

[3]  Hyo-Sang Park,et al.  BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. , 2003, Biochemical and biophysical research communications.

[4]  R. Thomas,et al.  Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor. , 1998, Gene.

[5]  C. Dickson,et al.  Skeletal disorders associated with fibroblast growth factor receptor mutations. , 1997, Current opinion in genetics & development.

[6]  Makoto Sato,et al.  Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.

[7]  W. Reardon,et al.  A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome , 1994, Nature Genetics.

[8]  Y. Bae,et al.  Spatio-temporal expression patterns of Runx2 isoforms in early skeletogenesis , 2002, Experimental & Molecular Medicine.

[9]  B. Olsen,et al.  Progression of calvarial bone development requires Foxc1 regulation of Msx2 and Alx4. , 2003, Developmental biology.

[10]  G. Stein,et al.  Runx1/AML1 hematopoietic transcription factor contributes to skeletal development in vivo , 2003, Journal of cellular physiology.

[11]  M. Owen,et al.  Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia , 1997, Cell.

[12]  M. Longaker,et al.  The BMP antagonist noggin regulates cranial suture fusion , 2003, Nature.

[13]  C. Deng,et al.  A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. , 2000, Human molecular genetics.

[14]  G. Stein,et al.  Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells , 1990, Journal of cellular physiology.

[15]  Y. Kim,et al.  Differential Expression Patterns of Runx2 Isoforms in Cranial Suture Morphogenesis , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  A. Monsoro-Burq,et al.  BMP signals regulate Dlx5 during early avian skull development. , 2003, Developmental biology.

[17]  Jae-Hyun Sung,et al.  BMP-2-induced Runx2 Expression Is Mediated by Dlx5, and TGF-β1 Opposes the BMP-2-induced Osteoblast Differentiation by Suppression of Dlx5 Expression* , 2003, Journal of Biological Chemistry.

[18]  D. Rice,et al.  FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. , 1998, Development.

[19]  M. Eccles,et al.  Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2 , 1994, Nature Genetics.

[20]  D. Rice,et al.  Integration of FGF and TWIST in calvarial bone and suture development. , 2000, Development.

[21]  M. Evans,et al.  Crouzon‐like craniofacial dysmorphology in the mouse is caused by an insertional mutation at the Fgf3/Fgf4 locus , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[22]  I. Munro,et al.  Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans , 1995, Nature Genetics.

[23]  M. Ito,et al.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. , 2000, The Journal of clinical investigation.

[24]  G. Dorn,et al.  Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. , 1995, Molecular biology of the cell.

[25]  J. Wozney,et al.  Runx2 Is a Common Target of Transforming Growth Factor β1 and Bone Morphogenetic Protein 2, and Cooperation between Runx2 and Smad5 Induces Osteoblast-Specific Gene Expression in the Pluripotent Mesenchymal Precursor Cell Line C2C12 , 2000, Molecular and Cellular Biology.

[26]  Sue Malcolm,et al.  Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome , 1994, Nature Genetics.

[27]  G. Stein,et al.  Transient upregulation of CBFA1 in response to bone morphogenetic protein‐2 and transforming growth factor β1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation , 1999, Journal of cellular biochemistry.

[28]  A I Caplan,et al.  Stimulatory Effects of Basic Fibroblast Growth Factor and Bone Morphogenetic Protein‐2 on Osteogenic Differentiation of Rat Bone Marrow‐Derived Mesenchymal Stem Cells , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.